75N91025F00001↗
Mriglobal received this contract from Nih Nci, National Institutes of Health: $3.46M obligated so far for reference laboratory testing. It runs to 2027-09-21.
Key facts · data as of Oct 25, 2026
- Recipient
- Mriglobal
- Awarding agency
- National Institutes of Health (Department of Health and Human Services)
- Contracting office
- Nih Nci (75N910)
- Obligated to date
- $3.46M
- Potential value
- $3.46M
- Ends
- 2027-09-21
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.
Cite this page: SpendQuery, Award 75N91025F00001, data as of Oct 25, 2026, https://spendquery.com/award?id=CONT_AWD_75N91025F00001_7529_75N91023D00010_7529
Mriglobal: all federal awards · Department of Health and Human Services: spending · Nih Nci: what it buys · The follow-on: recompete brief
MANUFACTURE OF CLINICAL GRADE EPSTEIN-BARR VIRUS VACCINE
Up for re-bid: ends 2027-09-21. Recompete brief →
What it is
- Product or service
- Reference Laboratory Testing (PSC Q301)
- Industry
- Other Scientific and Technical Consulting Services (NAICS 541690)
- Contracting office
- Nih Nci (75N910)
- Competition
- Full and open competition
- Pricing
- Firm fixed price
- How it was bought
- Single-award IDIQ · under 75N91023D00010
- Solicitation
- EBV-2025-01
- Where the work is
- Jackson, MO · district MO-05
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
1 subaward totaling $2.92M (84.5% of what was obligated), as Mriglobal reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.
| Subcontractor | Amount | Subawards | Where | First | Last |
|---|---|---|---|---|---|
| HDT Bio Corp | $2.92M | 1 | WA | 2025-10-22 | 2025-10-22 |
The largest single subawards
| Date | To | Amount | For |
|---|---|---|---|
| 2025-10-22 | HDT Bio Corp | $2.92M | TECHNOLOGY TRANSFER, ANALYTICAL METHODS, PRODUCTION, TESTING, AND MASTER CELL BANK. |
Every action
3 actions since 2025-09-22. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-05-08 | P00002 | Administrative change | $0 | MANUFACTURE OF CLINICAL GRADE EPSTEIN-BARR VIRUS VACCINE |
| 2026-03-05 | P00001 | Administrative change | $0 | MANUFACTURE OF CLINICAL GRADE EPSTEIN-BARR VIRUS VACCINE |
| 2025-09-22 | 0 | $3.46M | MANUFACTURE OF CLINICAL GRADE EPSTEIN-BARR VIRUS VACCINE |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗